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Abstract: A simple and accurate high- performance liquid chromatography (HPLC) coupled with diode array detector
(DAD) and evaporative light scattering detector (ELSD) was established for the determination of six bioactive compounds
in Zhenqi Fuzheng preparation (ZFP). The monitoring wavelengths were 254. 275 and 328 run. Under the optimum
conditions, good separation was achieved, and the assay was fully validated in respect of precision, repeatability and
accuracy. The proposed method was successfully applied to quantify the six ingredients in 31 batches of ZFP samples and
evaluate the variation by hierarchical cluster analysis (HCA). which demonstrated significant variations on the content of
these compounds in the samples from different manufacturers with different preparation procedures. The developed
HPLC method can be used as a valid analytical method to evaluate the intrinsic quality of this preparation.
Keywords: high-performance liquid chromatography (HPLC); diode array detector (DAD); evaporative light scattering
detector (ELSD); Zhenqi Fuzheng preparation; quantification; hierarchical cluster analysis
1 Introduction
Traditional Chinese medicines (TCMs). used for thousands
of years in China. have played an important role in clinical
therapy[I.2]. Therefor, to ensure the clinical efficacy and
safety, overall quality control of TCMs is of significant im-
portance[3]. However, most of the published literature has
reported the qualitation or quantification of one or two
types of components from only one comprising herb, and it
could not be responsible for the overall quality control of
the composite formulae [4]. Therefore, it seems necessary
to determine the marker compounds of Chinese medicine
preparation (CMP)[ 5] . .
Zhenqi Fuzheng preparation (ZFP), composed of Radix
Astragali (Huangqi in Chinese) and Fructus Ligustri Lucidi
(Niizhenzi in Chinese), which has been listed in "Ministry
of Health Drug Standards" of Chinese medicine formulated
prescription,' is commonly used in clinical practice for the
treatment to improve immunity, protect bone marrow and
adrenal cortex, increase leukocytes, promote the recovery
of normal functions as an accessory of surgical operation,
radiotherapy or chemotherapy, and it could also be used as
an adjuvant therapy of cancer[6-10] .
It is proved that the biologically active components in
Huangqi, Niizhenzi and ZFP include isoflavonoids,
triterpene sapogenins, glycosides, saponin and phenolic
acids[1l-14]. Therefore, developing a simple and sensitive
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method to determine these ingredients becomes essential for
quality control of this preparation. Although many analyti-
cal methods have been reported for the qualitative evalua-
tion of the crude drug of Huangqi or Niizhenzi, or their
combined prescriptions, including high-performance liquid
chromatography (HPLC)-ultraviolet (UV) or diode array
detector (DAD)[15-17], thin layer chromatography scan-
ning (TLCS) [18], chemiluminescence-mass spectrometry
(LC- MS) [ 19-22]' and HPLC-evaporative light scattering
detector (ELSD) [23], there is no report on simultaneous
determination of the six components as yet.
In the present study. we developed the HPLC-DAD-
ELSD method to determine six components of ZFP, inclu-
ding adenosine (l), rhodioside (2), chlorogenic acid (3),
calycosin (4), fermononetin (5), and astragaloside IV (6),
as shown in Figure 1. This approach is potentially ideal for
routine analysis and quality evaluation of ZFP. In order to
improve the sensitivity and selectivity of the determination,
DAD at three different wavelengths was employed for the
quantitative analysis of strong UV absorbing compounds
such as phenolic acids and isoflavones due to their different
UV characteristics, while ELSD was used to determine
none or poor UV absorbing compounds such as saponins.
2 Experimental
2.1 Instruments
HPLC analysis was carried out with a Waters Liquid Chro-
matography (Alliance, USA), 2996 diode array detector
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and evaporative light scattering detector (Alltech, USA), a
Waters 717 automatic injector and MJ2 ADD-ON single sys-
tem, using a Hypersil ODS column (4.6 rom x 250 rom,
5 !-Lm, Dalian Elite Analytical Instruments Co., Ltd.,
Dalian, China).
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Figure 1 Structures of six standard substances
2.2 Chromatographic conditions
The mobile phase consisted of methanol (A) and water (B)
in a gradient elution mode as follows: 0 - 10 min, A : B
(10 : 90, v/v); 10 - 30 min, linear gradient from A : B
(10 : 90, v/v) to A: B (40 : 60, v/v); 30 - 65 min, linear
gradient to A: B (60 : 40, v/v); 65 - 90 min, the linear
gradient to A: B (l00 : 0, v/v). The column temperature
was maintained at 30 'c and the flow rate was 1. 0 mU
min. An aliquot of 10 !-LL of each sample was injected.
Detection wavelengths were set at 254 nm for adenosine,
calycosin, and fermononetin, 275 nm for rhodioside, and
328 nm for chlorogenic acid. The drift tube temperature for
ELSD and carrier gas flow rate were 115'C and 3. OUmin,
respectively.
2.3 Otemicals and samples
Compounds (4) (99.83% purity) and (5) (99.37% purity)
were supplied by Shanghai Institute of Chinese Materia
Medica (Shanghai, China), and the other standard sub-
stances (1, 2, 3, and 6) were purchased from National
Institute for the Control of Pharmaceutical and Biological
Products (Beijing, China). Methanol (HPLC grade) was
provided by Yuwang Chemical Co., Ltd. (Shandong,
China). All solutions were prepared with double-deionized
water. Other reagents were all of analytical grade. Thirty-
one batches of ZFP were obtained from different pharma-
ceutical companies in China.
2.4 Preparation of ~Ie solutions and negative control (NC)
solutions
ZFPs were triturated in the particle size of 40 - 60 mesh.
The accurately weighed powder (2.0000 g) was extracted
three times with aliquots of 30 mL methanol by sonication
(400 W, 30 min). Then the pooled filtrate was concentrated
to dryness, and the residue was dissolved in 5 mL methanol.
The methanol solution was filtered with a 0.45 !-Lm mem-
brane prior to HPLC analysis. According to the prescrip-
tion and preparation protocol of ZFP recorded in Chinese
Ministry of Health Drug Standards, two kinds of NC sam-
ples in which the formula contained no Niizhenzi (El) and
Huangqi (B2), respectively, were prepared to validate the
specificity of the method. The NC sample solutions were
prepared using the same method as the sample solutions.
2.5 Standard calibration curves
Standard stock solutions of the compounds 1 - 6 were pre-
pared by dissolving precisely weighted portions of the
standards in methanol to give the concentrations of 0.322,
0.422, 0.502, 0.526, 0.182, and 1. 695 mglmL, respec-
tively. The stock solutions were further diluted with metha-
nol to get 9 different concentrations (equivalent to 1/20, 1/
10, 3/20, 1/5, 1/4, 3/10, 7120, 2/5, and 1/2 of the orig-
inal concentration). Subsequently, an aliquot of 10!-LL of
the resulting solutions was injected into HPLC for analysis.
3 Results and discussion
3.1 Development of extraction method
To obtain quantitative extraction, the main experiment
factors including extraction solvent (methanol and etha-
nol), extraction method (Soxhlet extraction and ultrasonic
extraction) and extraction time (15, 30, and 45 min) were
investigated, and the optimal conditions are presented in
detail in Section 2.4.
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3.2 Optimization of chromatographic conditions
To optimize the chromatographic conditions, the different
stationary phases, such as Kromasil ODS column (5 f-lm,
4.6 mm x 25 mm) and Hypersil ODS-l column (5 f-lm,
4.6 mm X 25 mm), and different mobile phases, such as
methanol : water and acetonitrile : water, were attempted
during the experiment. As a result, a Kromasil ODS
column and the mobile phase of methanol: water were
chosen to obtain the desired separation and acceptable
tailing factor within the running time of 90 min.
In our previous work (data not shown), these bioactive
components have slightly different UV absorption proper-
ties, and it is difficult to simultaneously determine them by
common analytical approaches. Therefore, three detection
wavelengths at 254, 275, and 328 rim were used to record
chromatograms for the different structural types of compo-
nents, and to provide an optimum SIN for simultaneously
quantitative analysis. The operating conditions for ELSD
were optimized according to the data computed with the
ELSD software: The gas flow rate was set at 3.0 Umin,
and the drift tube temperature was determined to be
115°C. Chromatograms of ZFP under such detection con-
ditions are shown in Figure 2 and Figure 3.
Based on the selected detection mode, all these six com-
pounds had acceptable limits of detection (LOD) and quan-
tification (LOQ) (Table 1). The identity of each peak
detected in ZFP samples was confirmed by comparison of
retention time, UV spectrum of each peak with those of
reference compound and blank samples. In addition,
spiking samples with the reference compounds further
confirmed the identities of the peaks.
3.3 Validation of the method
3.3.1 Linearity, WD and U>Q
The construction of calibration curves was carried out
according to the section 2.5. For the components by UV
detection, their regression equations were expressed by the
formula Y = AX + B, while by ELSD detection, their
regression equations could be described as Y = aXb ; so, the
calibration curves should be obtained in double logarithmic
coordinates [ 11 ]. As shown in Table 1, a good linearity
( r>0.999) was observed in a relatively wide concentration
range.
Working solution was diluted with methanol to get a
series of appropriate concentrations, and the LOD and
LOQ under the chromatographic conditions were separately
determined at the signal- to- noise ratios (SIN) of 3 and 10.
LOD and LOQ for each compound are also listed in Table 1.
3.3.2 Precision, repeatability, and accuracy
The precision of this newly developed method was studied
by determining intra-day and inter-day variations. The
intra-day variation was determined by analyzing the same
standard methanol solution in triplicate for three times
within one day. While for inter-day variation test, the solu-
tion was examined in triplicate for consecutive three days.
To estimate the repeatability, five different working solu-
tions, which were prepared from the same sample, were
analyzed. As indicated in Table 2, the overall RSDs of the
precision test and the repeatability test were lower than
2.63%, which demonstrates good precision and repeatabili-
ty of the method.
Figure 2 The typical HPLC-DAD chromatographic profiles. A, B, C, and D
stand for standard solution, ZFP in absence of Niizhenzi, ZFP in absence of
Huangqi, and ZFP in sequence. Peaks 1, 2, 3, 4, and 5 represent adenosine,
rhodioside, chlorogenic acid, calycosin, and fermononetin, respectively. Blank
sample analysis confirms that no impurities were co-eluted with the compounds
determined .
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Thble 1 Regression data, LODs and LOQs of six analytes by HPLC-DAD and HPLC-ELSD
Analyte Calibration curve' r Linear range (Il-g) LOD (ng) LOQ (ng)
Adenosine Y = 8.18 X 10' X - 5.79 X 10' 0.9999 0.161 -1.126 10.6 15.1
Rhodioside Y=6.08xI0' X-1.11xI0' 0.9999 0.211-1.266 5.3 8.7
Chlorogenic acid Y =7.18 X 10' X -1.48 X 105 0.9992 0.251 -1. 506 2.9 4.2
Calycosin Y = 3 .24 X 105 X -1.03 X 106 0.9993 0.263 - 1. 578 2.1 3.9
Fermononetin Y = 9.67 X 10' X - 3.67 X 105 0.9990 0.182 - 0.546 2.5 4.2
Astragaloside IV A = 1.35 B + 3 .91 0.9997 0.848- 5.085 96 128
, Y is the peak area in UV chromatograms monitored at detection wavelengths, X is the compound amount injected, and A, B are the logarithmic values of area
and amount injected in ELSD chromatograms.
Thble 2 Precision and repeatability of the six analytes
Repeatability (n =5)Precision
Intra-day (n = 3) Inter-day (n = 3)
Mean (mg/g) RSD (%) Mean (mg/g) RSD (%) Mean (mg/mL) RSD (%)
Analyte
Adenosine 0.3156 1. 36 0.3157 1. 82 0.0437 2.32
Rhodioside O. 4303 1. 32 0.4298 2.41 0.4783 2. 58
Chlorogenic acid 0.4970 1. 35 0.4975 1. 57 O. 0571 1. 85
Calycosin 0.5207 1.10 0.5309 2.36 0.3503 2.63
Fermononetin 0.1784 1. 78 0.1798 2.13 0.2809 2.27
Astragaloside IV 1. 7201 O. 95 1. 6778 1. 18 O. 6450 1. 54
The overall RSD of the intra- and inter-day is in the range of 0.95% -1. 36% and 1.18% - 2. 41 %, respectively. And the RSD of repeatability test is <3%.
Figure 3 The typical HPLC-ELSD chromatographic profiles. A, B,
and C stand for standard solution, ZFP in absence of Niizhenzi, and
ZFP in sequence. NC sample analysis confirms that no impurities were
co-eluted with the compounds determined.
The accuracy of the method was evaluated by spiking
known amounts of standard samples into a ZFP sample and
comparing the amount determined of these standards with
the amount originally added. And as shown in Table 3, the
overall RSD of the recovery of ZFP was lower than 3% for
all these analyses. The recovery obtained was in the range
of 95.4% -103.5%, indicating that the developed method
was sufficiently accurate for determining the six bioactive
components in ZFP, and analysis of NC samples confirmed
that no impurities were co-eluted with the compounds
determined (Figure 2 and Figure 3).
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31 batches of ZFP samples are summarized in Table 4. The
results showed that the quality of this preparation was
relatively uniform and demonstrated that the chemical
variation was obvious among the different companies and!
or preparations of ZFP.
Thble 3 Recovery of the six analytes
Original Spiked Found Recovery RSD
Analyte mean mean mean mean (%)
(mg) (mg) (mg) (%) (n = 3)
Adenosine 0.0874 0.0866 0.1726 98.4 2.95
Rhodioside 0.9566 0.9065 1.8738 101.2 1.76
Chlorogenic acid 0.1142 0.0902 0.2024 98.3 2.82
Calycosin 0.7006 0.6882 1.3930 100.6 1.56
Fermononetin 0.5618 0.5534 1.0896 95.4 2.93
Astragaloside IV 1.2825 1.2794 2.6067 103.5 2.79
Thble 3 shows the accuracy of repeatability test with RSD <3%.
Recovery mean (%) = [(Found mean-Original mean)/Spiked mean] x 100
The results showed that the content of astragaloside IV
(6), a characteristic and active constituent whose presence
forms part of the quality assurance of ZFP, is relative high
in samples compared with the other target compositions.
The contents of the compounds were found lower in granule,
and higher in capsule, except compound 2. Therefore, the
analytical results obtained also indicated that a multiple-
component assay might be a rational strategy to elucidate
the synergic effects and much more comprehensive control
for the quality of this preparation.
3.5 Comparison of different batches of ZFP
3.4 Analysis of samples
The developed method was subsequently applied to simulta-
neous determination of the six active compounds in 31
commercial ZFP samples from different pharmaceutical
companies in China. All the contents of six ingredients in
To evaluate the variation of ZFP, hierarchical cluster
analysis (HCA) was performed based on the investigated
components' characteristics from HPLC profiles of 31 test
samples. The dendrogram of HCA is shown in Figure 4,
and the quality characteristics are revealed more clearly.
Supposing an appropriate distance level (Level D is chosen,
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the samples can be classified into seven quality groups,
thereby indicating that preparation procedure is related to
the quality of products. If a higher distance level (Level m
is adopted, samples 1 - 19 tend to be classified into the
same group, which indicates that the samples from the
same manufacturer are more similar, and then the samples
can be divided into five quality groups, among which there
is an abnormal sample (No,28), Thus, RCA is an effective
way to discover the abnormal sample rapidly.
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Figure 4 The cluster analysis of chromatograms of 31 ZFP samples. Level I was used to distinguish different dosage forms of preparation.
Level II was used to distinguish different manufacturers of samples 1-19. An abnormal sample (No.28) can be discovered obviously.
4 Conclusion
We reported a simple and sensitive HPLC method coupled
with DAD and ELSD, and these two detectors are comple-
mentary, The proposed HPLC-DAD-ELSD method makes
it possible to evaluate the quality of ZFP through a determi-
nation of multi-components with different structures. This
method has been applied successfully to quantify six bioac-
tive compounds in 31 different batches of ZFP samples.
The results prove that the present method is suitable for
routine quantitative analysis and intrinsic quality control of
ZFP.
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Thble 4 Content of six compounds in 31 batches of ZFP samples (mglg)
25
Sample No. Adenosine Rhodioside Rhlorogenic acid
1 0.0437 0.4783 0.0571
2 0.0400 0.3953 0.0554
3 0.0500 0.4082 0.0502
4 0.0474 0.4217 0.0576
5 0.0450 0.4323 0.0539
6 0.0265 0.4772 0.0545
7 0.0283 0.4533 0.0595
8 0.0294 0.4773 0.0640
9 0.0268 0.3935 0.0633
10 0.0318 0.6395 0.0349
11 0.0310 0.7387 0.0344
12 0.0234 0.4137 0.0348
13 0.0297 0.3600 0.0219
14 0.0294 0.1648 0.0214
15 0.0352 0.2885 0.0302
16 0.0435 0.3852 0.0339
17 0.0344 0.2711 0.0353
18 0.0300 0.3191 0.0306
19 0.0387 0.3022 0.0255
20 0.0450 0.2715 0.0332
21 0.0447 0.1678 0.0370
22 0.0266 0.1693 0.0343
23 0.0254 0.1897 0.0383
24 0.0052 0.3154 0.0616
25 0.0052 0.2927 0.0598
26 0.0050 0.3540 0.0414
27 0.0010 0.3381 0.0625
28 0.0088 1.4742 0.0883
29 0.0101 0.0747 0.0226
30 0.0153 0.1576 0.0122
31 0.0133 0.3806 0.0217
Calycosin
0.3503
0.3394
0.3252
0.3701
0.3459
0.3189
0.3070
0.3265
0.3291
0.2601
0.2599
0.2347
0.2650
0.1956
0.2890
0.2271
0.1958
0.2677
0.2170
0.3341
0.3594
0.3673
0.3442
0.3978
0.3679
0.3665
0.3491
0.3216
0.2171
0.1544
0.2045
Fermononetin
0.2809
0.3214
0.2484
0.3120
0.2718
0.2749
0.2650
0.2000
0.2380
0.3006
0.2113
0.2188
0.2165
0.2547
0.2540
0.2539
0.1999
0.2368
0.1933
0.3489
0.3286
0.2986
0.3721
0.3115
0.3039
0.3278
0.3073
0.2571
0.1247
0.1291
0.1671
Astragaloside N
0.6450
0.6384
0.6294
0.6755
0.6602
0.6625
0.6767
0.6416
0.6606
0.6275
0.6780
0.6167
0.6405
0.6306
0.6620
0.6029
0.6346
0.6865
0.7406
0.8776
0.8484
0.8890
0.9180
0.7820
0.7685
0.7969
0.8012
0.6030
0.7024
0.5575
0.6367
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